.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Merck
Deloitte
Boehringer Ingelheim
Citi
Fuji
Novartis
US Army
Johnson and Johnson
Harvard Business School

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019849

« Back to Dashboard
NDA 019849 describes DAPIPRAZOLE HYDROCHLORIDE, which is a drug marketed by Fera Pharms and is included in one NDA. Additional details are available on the DAPIPRAZOLE HYDROCHLORIDE profile page.

The generic ingredient in DAPIPRAZOLE HYDROCHLORIDE is dapiprazole hydrochloride. There are two drug master file entries for this compound. Additional details are available on the dapiprazole hydrochloride profile page.

Summary for NDA: 019849

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 31, 1990TE:RLD:Yes

Expired Orange Book Patents for NDA: 019849

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fera Pharms
DAPIPRAZOLE HYDROCHLORIDE
dapiprazole hydrochloride
SOLUTION/DROPS;OPHTHALMIC019849-001Dec 31, 19904,252,721► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Merck
UBS
Express Scripts
Colorcon
Accenture
Cipla
Deloitte
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot